Mark L. Messonnier

TL;DR: The results highlight the enormous annual burden of influenza in the US, with hospitalization costs and lost productivity from missed work days and lost lives comprise the bulk of the economic burden.

TL;DR: From both direct cost and societal perspectives, vaccinating children as recommended with these vaccines results in substantial cost savings, and routine childhood immunization among members of the 2009 US birth cohort will prevent ∼42 000 early deaths and 20 million cases of disease.

TL;DR: Routine childhood immunization with the 7 vaccines was cost saving from the direct cost and societal perspectives, with net savings of 9.9 billion dollars and 43.3 billion dollars, respectively.

TL;DR: It is estimated that mean maximum willingness-to-pay (WTP) for current HPV vaccine technology ranges between $560 and $660, and mothers strongly valued greater cervical cancer efficacy, with 100% protection against cervical cancers the most desired feature overall.

TL;DR: Responses were willing to pay larger amounts to avoid increased risk of minor adverse events and to increase community-level immunization coverage than to avoid injections, which should be taken into account when determining the risks and benefits of combination vaccines.